YALE-NEW HAVEN HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $12.9M
- Transactions
- 1,411
- Companies
- 40
- Average per transaction
- $9,143
Who reported the payments
| Seagen Inc. | $2,177,944 |
| AbbVie | $1,005,545 |
| Siemens Medical Solutions USA, Inc. | $803,697 |
| Novartis | $680,701 |
| Boston Scientific | $543,248 |
| E.r. Squibb & Sons, L.L.C. | $456,940 |
| Pfizer | $433,250 |
| Diagnostica Stago, Inc | $349,606 |
| Almirall LLC | $330,607 |
| Cepheid | $298,656 |
| Transmedics, Inc. | $246,810 |
| Argenx US, Inc. | $237,836 |
| Sanofi | $229,937 |
| Jazz Pharmaceuticals Inc. | $228,653 |
| United Imaging Healthcare North America, Inc. | $227,227 |
| Bracco Diagnostics Inc. | $225,129 |
| Karyopharm Therapeutics Inc. | $204,451 |
| National Marrow Donor Program | $199,380 |
| Servier Bioinnovation | $198,926 |
| Genentech USA, Inc. | $195,000 |
| Sage Therapeutics, LLC | $187,510 |
| Cardiva Medical, Inc. | $175,013 |
| Gen-probe, Inc. | $171,032 |
| Beckman Coulter, Inc. | $165,061 |
| Kls-martin L.p. | $155,185 |
| Tesaro, Inc. | $151,685 |
| Conformis, Inc. | $147,677 |
| Lilly USA, LLC | $137,500 |
| Takeda Pharmaceuticals U.S.A., Inc. | $131,745 |
| Merck | $120,314 |
| Angiodynamics, Inc. | $109,887 |
| Caption Health, Inc. | $99,996 |
| Stryker | $99,929 |
| Arrow International, Inc. | $96,491 |
| Heron Therapeutics, Inc. | $88,403 |
| Progenics Pharmaceuticals, Inc. | $79,594 |
| C. R. Bard, Inc. & Subsidiaries | $76,139 |
| Clearpoint Neuro, Inc. | $74,682 |
| Beigene, Ltd. | $72,856 |
| Orthofix Medical, Inc. | $68,623 |